Open access
Aug 2026
Pharmacological inhibition of BUB1 suppresses UCEC progression by modulating the PI3K-AKT pathway and reversing anoikis resistance and immune evasion: a multi-omics and experimental study
BUB1 was significantly upregulated in UCEC tumors compared with normal endometrium, associated with advanced disease stage and reduced overall survival, confirming its role as an unfavorable prognostic biomarker and therapeutic target in UCEC.
Wajahat Ali, Md. Abdullah Al Mamun, Yi-Cheng He et al.
· Future Journal of Pharmaceut... · 0 citations